Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
Department of Health and Human Services
The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics (ART).This initiative aims to understand intricate mechanisms of immune cells at the maternal-fetal interface, T and B cell development and maturation in offspring, and local immune responses and the role of systemic immunity.
Funding
Award size
$100K – $1M
Award ceiling
400000
Type
Grant
Dates
Deadline
Later
Posted
12/30/2024
Closes
2028-11-05
Eligibility
Eligibility
Public and State controlled institutions of higher educationPublic housing authorities/Indian housing authoritiesCity or township governmentsPrivate institutions of higher educationState governmentsOthers (see text field entitled "Additional Information on Eligibility" for clarification)For profit organizations other than small businessesNative American tribal organizations (other than Federally recognized tribal governments)County governmentsNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationSmall businessesSpecial district governmentsNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationNative American tribal governments (Federally recognized)Independent school districts
Program
Funding area
Health - HLIncome Security and Social Services - ISS
Opportunity #
PAR-25-362
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov